Serenase 5 mg tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

serenase 5 mg tabletter

essential pharma limited - haloperidol - tabletter - 5 mg

Serenase Dekanoat 100 mg/ml injektionsvæske, opløsning Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

serenase dekanoat 100 mg/ml injektionsvæske, opløsning

essential pharma limited - haloperidoldecanoat - injektionsvæske, opløsning - 100 mg/ml

Serenase Dekanoat 50 mg/ml injektionsvæske, opløsning Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

serenase dekanoat 50 mg/ml injektionsvæske, opløsning

essential pharma limited - haloperidol - injektionsvæske, opløsning - 50 mg/ml

Efedrin "Unimedic" 5 mg/ml injektionsvæske, opløsning Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

efedrin "unimedic" 5 mg/ml injektionsvæske, opløsning

unimedic pharma ab - ephedrinhydrochlorid - injektionsvæske, opløsning - 5 mg/ml

Mektovi Den Europæiske Union - dansk - EMA (European Medicines Agency)

mektovi

pierre fabre medicament - binimetinib - melanom - antineoplastiske midler - binimetinib i kombination med encorafenib er indiceret til behandling af voksne patienter med inoperabel eller metastatisk melanom med en braf v600 mutation.

Ozawade Den Europæiske Union - dansk - EMA (European Medicines Agency)

ozawade

bioprojet pharma - pitolisant - sleep apnea, obstructive - andre narkotika stoffer - ozawade is indicated to improve wakefulness and reduce excessive daytime sleepiness (eds) in adult patients with obstructive sleep apnoea (osa).

Sebadrin 50 mg/ml injektionsvæske, opløsning Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

sebadrin 50 mg/ml injektionsvæske, opløsning

2care4 generics aps - ephedrinhydrochlorid - injektionsvæske, opløsning - 50 mg/ml

Teriflunomide Mylan Den Europæiske Union - dansk - EMA (European Medicines Agency)

teriflunomide mylan

mylan pharmaceuticals limited - teriflunomide - multipel sklerose, recidiverende-remitterende - immunosuppressiva - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).

Teriflunomide Accord Den Europæiske Union - dansk - EMA (European Medicines Agency)

teriflunomide accord

accord healthcare s.l.u. - teriflunomide - multipel sklerose, recidiverende-remitterende - immunosuppressants, selektiv immunosuppressive - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).

Duodopa 240+12 mg/ml infusionsvæske, opløsning Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

duodopa 240+12 mg/ml infusionsvæske, opløsning

abbvie a/s - foscarbidopa, foslevodopa - infusionsvæske, opløsning - 240+12 mg/ml